Skip to content

Clinical trials

Phase 2 Hepatitis, Alcoholic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis, Alcoholic Phase: Phase 2 Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20133
20143
20161
20171
20181
20192
20201
20212
20221
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Not yet recruiting1
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Conatus Pharmaceuticals Inc.2
Durect2
Virginia Commonwealth University2
Aldeyra Therapeutics, Inc.1
Craig James McClain1
Gilead Sciences1
Hospital Universitari Vall d'Hebron Research Institute1
Imperial College London1
Indiana University1
Intercept Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis, Alcoholic21
Hepatitis3
Liver Diseases3
Acute-On-Chronic Liver Failure2
Alcoholism2
Fibrosis2
Liver Cirrhosis, Alcoholic2
Liver Diseases, Alcoholic2
Bacterial Infections1
Fatty Liver, Alcoholic1

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.